These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3192039)

  • 1. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.
    Watanabe J; Wohltmann HJ; Klein RL; Colwell JA; Lopes-Virella MF
    Diabetes; 1988 Dec; 37(12):1652-7. PubMed ID: 3192039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
    Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
    Shattil SJ; Bennett JS; Colman RW; Cooper RA
    J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of aspirin on platelet aggregation in IDDM.
    Mori TA; Vandongen R; Douglas AJ; McCulloch RK; Burke V
    Diabetes; 1992 Mar; 41(3):261-6. PubMed ID: 1551486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of prostaglandin synthesis in washed human platelets and cultured bovine aortic endothelial cells by glycosylated low density lipoprotein.
    Ishii H; Umeda F; Kunisaki M; Yamauchi T; Nawata H
    Diabetes Res; 1989 Dec; 12(4):177-82. PubMed ID: 2637093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in platelets and vascular endothelial cells induced by glycated lipoproteins.
    Takeda H; Yano T; Kishikawa H; Miyata T; Shinohara M; Yamaguchi E; Kobori S; Fan JL; Tokunaga O; Shichiri M
    Intern Med; 1992 Jun; 31(6):746-51. PubMed ID: 1392175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane.
    Beitz J; Schimke E; Liebaug U; Block HU; Beitz A; Honigmann G; Sziegoleit W; Müller G; Mest HJ
    Klin Wochenschr; 1986 Sep; 64(17):793-9. PubMed ID: 3531705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified forms of low density lipoprotein affect platelet aggregation in vitro.
    Aviram M
    Thromb Res; 1989 Mar; 53(6):561-7. PubMed ID: 2734732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus.
    Zoltowska M; Delvin E; Ziv E; Peretti N; Chartré M; Levy E
    Lipids; 2004 Jan; 39(1):81-5. PubMed ID: 15055239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of ADP-induced platelet aggregation in diabetes mellitus.
    Jones DB; Davis TM; Bown E; Carter RD; Mann JI; Prescott RJ
    Diabetologia; 1986 May; 29(5):291-4. PubMed ID: 3721088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol.
    Subbiah MT; Gallon L; Yunker R
    Pharmacology; 1980; 21(6):396-9. PubMed ID: 7220591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects.
    Winocour PD; Watala C; Kinglough-Rathbone RL
    Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Tohoku J Exp Med; 1984 Jun; 143(2):161-9. PubMed ID: 6474447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
    Mayfield RK; Halushka PV; Wohltmann HJ; Lopes-Virella M; Chambers JK; Loadholt CB; Colwell JA
    Diabetes; 1985 Nov; 34(11):1127-33. PubMed ID: 3930325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
    Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF
    Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.